Please assess the completion status of the following clinical trial:

Trial Title: Permission to Collect Blood Over Time for Research

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: COHORT
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Male or female, \>= 18 years old. There are no ethnic restrictions.~* Active cancers of the GI tract (gastroesophageal, colorectal, or pancreatic-biliary) that have completed TNM staging by the American Joint Committee on Cancer; stage III disease if diagnosed within 2 months and all stage IV disease~* Ability to understand and the willingness to sign a written informed consent document.~* Existing staging CT imaging study~Exclusion Criteria:~* Life expectancy \< 6 months~* History of deep vein thrombosis (DVT) or pulmonary embolism (PE)~* Known pregnancy or positive urine pregnancy test in pre-menopausal women~* On anticoagulant therapy (heparin, warfarin, direct thrombin inhibitors)~* No CT imaging studies, or contraindications to undergoing CT imaging~* Existing or anticipated need for a tunneled central venous catheter~* Clinic visitation to Stanford Cancer center for secondary consultation purposes only~* Inability to give informed consent

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).